companydata.dkAMPLEXA GENETICS A/S: Financial statements 2014
CVR: 29428441
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -185,712 and a net result of DKK -3,386,966 compared with DKK -5,860,653 the year before. Equity amounted to DKK -16,208,837.
- Gross Profit
- -185,712 kr.
- Profit/Loss
- -3,386,966 kr.
- Equity
- -16,208,837 kr.
- Total Assets
- 3,036,615 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -186 t. | -3.4 mio. | -16.2 mio. | - |
| 2013 | - | -786 t. | -5.9 mio. | -12.8 mio. | - |
| 2012 | - | -538 t. | -2.1 mio. | -7 mio. | - |
Keep an eye on AMPLEXA GENETICS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
AMPLEXA GENETICS A/S has published its annual report for 2013. Gross profit came to DKK -785,662, and the net result was DKK -5,860,653.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees. In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity amounted to DKK -10,313,267.